Objectives In adult diffuse glioma, preoperative detection of isocitrate dehydrogenase (IDH)
status helps clinicians develop surgical strategies and evaluate patient prognosis. Here, we …

Purpose: Isocitrate dehydrogenase (IDH) mutations in glioma patients confer longer survival
and may guide treatment decision making. We aimed to predict the IDH status of gliomas …

Purpose Isocitrate dehydrogenase (IDH) and 1p19q codeletion status are importantin
providing prognostic information as well as prediction of treatment response in gliomas …

Background Gliomas are the most common type of malignant brain tumor. Clinical outcomes
depend on many factors including tumor molecular characteristics. Mutation of the isocitrate …

Purpose Reliable and accurate predictive models are necessary to drive the success of
radiomics. Our aim was to identify the optimal radiomics-based machine learning method for …

Background Isocitrate dehydrogenase (IDH) mutation and 1p19q codeletion status have
been identified as significant markers for therapy and prognosis in lower-grade glioma …

Background and purpose Recent studies have highlighted the importance of isocitrate
dehydrogenase (IDH) mutational status in stratifying biologically distinct subgroups of …

Isocitrate dehydrogenase (IDH) mutant and wildtype glioblastoma multiforme (GBM) often
show overlapping features on magnetic resonance imaging (MRI), representing a diagnostic …

Radiomics based multi-variate models and state-of-art convolutional neural networks
(CNNs) have demonstrated their usefulness for predicting IDH genotype in gliomas from …

Background. High-grade gliomas with mutations in the isocitrate dehydrogenase (IDH) gene
family confer longer overall survival relative to their IDH-wild-type counterparts. Accurate …